Citius Oncology, Inc. ("Citius Oncology") (Nasdaq: CTOR), a majority-owned subsidiary of Citius Pharmaceuticals, Inc. (Nasdaq ...

CRBN/VHL, Targeted Glue™ degraders for oncology and immunology indications Cambridge, UK, 16 July 2025 – Amphista Therapeutics (“the Company” or “Amphista”), a leader in the discovery of ...

These proteins can have too many conformations for researchers to keep track of, says Kejia Wu, a postdoctoral researcher ...

David Baker’s lab has successfully designed binders to disordered proteins, expanding therapeutic access to over 50% of the human proteome.

Two years ago, Grafton learned he had stage 4 lung cancer. But thanks to a clinical trial at Duke funded by the National ...

Investigative journalist Gardiner Harris exposes Johnson & Johnson's dark secrets in his eye-opening book. Available on ...

The marketer of sun care products built a platform that turns consumer actions and user-generated content into opportunities ...

Sarina Wigeman and her Lionesses squad are defending champions and will be looking to retain the title they won in 2022 on ...

Despite rising immunisation rates, 14.3 million children received no protection from diphtheria, tetanus and whooping cough.

The 2025 Women's European Championships have officially kicked off in Switzerland, and it's going to be an amazing month of football, with cities like Basel, Bern, Zurich, Geneva and more hosting ...

The rankings continue to shift in favor of teams and the contenders looking to make some noise with the first half of the 2025 MLB season ...

The late Austrian billionaire Dietrich Mateschitz took a decade to graduate from university and started out marketing hygiene ...